For: | Ghosn M, Kourie HR, Karak FE, Hanna C, Antoun J, Nasr D. Optimum chemotherapy in the management of metastatic pancreatic cancer. World J Gastroenterol 2014; 20(9): 2352-2357 [PMID: 24605032 DOI: 10.3748/wjg.v20.i9.2352] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2352.htm |
Number | Citing Articles |
1 |
Zheng Wang, Jie Jiang, Tao Qin, Ying Xiao, Liang Han. EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway. Journal of Cellular and Molecular Medicine 2019; 23(4): 2678 doi: 10.1111/jcmm.14167
|
2 |
Jun Gong, Lori A. Robbins, Aurelia Lugea, Richard T. Waldron, Christie Y. Jeon, Stephen J. Pandol. Diabetes, pancreatic cancer, and metformin therapy. Frontiers in Physiology 2014; 5 doi: 10.3389/fphys.2014.00426
|
3 |
Jie Wu, Zhifang Li, Yong Li, Alex Pettitt, Feifan Zhou. Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618768637
|
4 |
Joshua Hamilton, Anne Breggia, Timothy L. Fitzgerald, Michael A. Jones, Peter C. Brooks, Karissa Tilbury, Andre Khalil. Multiscale anisotropy analysis of second-harmonic generation collagen imaging of human pancreatic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.991850
|
5 |
Morena Fasano, Carminia Maria Della Corte, Giovanni Vicidomini, Valerio Scotti, Pier Francesco Rambaldi, Alfonso Fiorelli, Marina Accardo, Ferdinando De Vita, Mario Santini, Fortunato Ciardiello, Floriana Morgillo. Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review. Oncology Letters 2016; 12(6): 4505 doi: 10.3892/ol.2016.5279
|
6 |
Ron Epelbaum, Einat Shacham-Shmueli, Baruch Klein, Abed Agbarya, Baruch Brenner, Ronen Brenner, Eliahu Gez, Talia Golan, Ayala Hubert, Ofer Purim, Mark Temper, Ella Tepper, Andreas Voss, Kenneth Russell, Addie Dvir, Lior Soussan-Gutman, Salomon M. Stemmer, Ravit Geva. Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/681653
|
7 |
Abdel Hadi Hajjar, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. FOLFIRINOX: A New Standard of Care In The Adjuvant Setting of Resectable Pancreatic Adenocarcinomas. Future Oncology 2019; 15(17): 1947 doi: 10.2217/fon-2019-0136
|
8 |
Bessi Qorri, Reza Bayat Mokhtari, William W. Harless, Myron R. Szewczuk. Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression. Cancers 2022; 14(6): 1374 doi: 10.3390/cancers14061374
|
9 |
Catherine Burkhart, Daria Fleyshman, Rachael Kohrn, Mairead Commane, Jennifer Garrigan, Vadim Kurbatov, Ilya Toshkov, Rajesh Ramachandran, Laura Martello, Katerina V. Gurova. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget 2014; 5(22): 11038 doi: 10.18632/oncotarget.2701
|
10 |
Shree Venkat, Peter J. Hosein, Govindarajan Narayanan. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol. Techniques in Vascular and Interventional Radiology 2015; 18(3): 153 doi: 10.1053/j.tvir.2015.06.006
|
11 |
Gina L. Razidlo, Christopher Magnine, Arthur C. Sletten, Rachel M. Hurley, Luciana L. Almada, Martin E. Fernandez-Zapico, Baoan Ji, Mark A. McNiven. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion. Cancer Research 2015; 75(14): 2907 doi: 10.1158/0008-5472.CAN-14-3103
|
12 |
Hiroki Kuroda, Masanori Tachikawa, Yasuo Uchida, Koetsu Inoue, Hideo Ohtsuka, Sumio Ohtsuki, Michiaki Unno, Tetsuya Terasaki. All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase. European Journal of Pharmaceutical Sciences 2017; 103: 116 doi: 10.1016/j.ejps.2017.02.021
|
13 |
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
|
14 |
Timothy L. Fitzgerald, Jason Brinkley, Shannon Banks, Nasreen Vohra, Zachary P. Englert, Emmanuel E. Zervos. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbeck's Archives of Surgery 2014; 399(8): 989 doi: 10.1007/s00423-014-1241-3
|
15 |
Nabin Khanal, Smrity Upadhyay, Sumit Dahal, Vijaya Raj Bhatt, Peter T. Silberstein. Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base. Therapeutic Advances in Medical Oncology 2015; 7(4): 198 doi: 10.1177/1758834015579313
|